Evidence map›Paper›PMID 30109764›Full record

Observational studyHealth expectations : an international journal of public participation in health care and health policy2018

Are component endpoints equal? A preference study into the practice of composite endpoints in clinical trials.

Melissa C W Vaanholt, Marlies M Kok, Clemens von Birgelen, Marieke G M Weernink, Janine A van Til

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in Health expectations : an international journal of public participation in health care and health policy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Reply: Composite endpoints in clinical trials - simplicity or perfection?EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology · 2022
    Article
  5. Article
  6. Similar long-term outcome of dissimilar drug-eluting stents: is it time to change the assessment?EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology · 2021
    Article
  7. Review
  8. Article
  9. Are component endpoints equal? A preference study into the practice of composite endpoints in clinical trials.Health expectations : an international journal of public participation in health care and health policy · 2018
    Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Melissa C W VaanholtDepartment of Health Technology and Services Research, MIRA - Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands.ORCID 0000-0002-5139-8501
Marlies M KokDepartment of Cardiology, Medisch Spectrum Twente, Thoraxcentrum Twente, Enschede, The Netherlands.
Clemens von BirgelenDepartment of Health Technology and Services Research, MIRA - Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands.ORCID 0000-0002-5128-2832
Marieke G M WeerninkDepartment of Health Technology and Services Research, MIRA - Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands.
Janine A van TilDepartment of Health Technology and Services Research, MIRA - Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands.
University of Twente · NLMedisch Spectrum Twente · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo examine patients' perspectives regarding composite endpoints and the utility patients put on possible adverse outcomes of revascularization procedures.

designIn the PRECORE study, a stated preference elicitation method Best-Worst Scaling (BWS) was used to determine patient preference for 8 component endpoints (CEs): need for redo percutaneous coronary intervention (PCI) within 1 year, minor stroke with symptoms <24 hours, minor myocardial infarction (MI) with symptoms <3 months, recurrent angina pectoris, need for redo coronary artery bypass grafting (CABG) within 1 year, major MI causing permanent disability, major stroke causing permanent disability and death within 24 hours.

settingA tertiary PCI/CABG centre.

participantsOne hundred and sixty patients with coronary artery disease who underwent PCI or CABG.

main outcome measuresImportance weights (IWs).

resultsPatients considered need for redo PCI within 1 year (IW: 0.008), minor stroke with symptoms <24 hours (IW: 0.017), minor MI with symptoms <3 months (IW: 0.027), need for redo CABG within 1 year (IW: 0.119), recurrent angina pectoris (IW: 0.300) and major MI causing permanent disability (IW: 0.726) less severe than death within 24 hours (IW: 1.000). Major stroke causing permanent disability was considered worse than death within 24 hours (IW: 1.209). Ranking of CEs and the relative values attributed to the CEs differed among subgroups based on gender, age and educational level.

conclusionPatients attribute different weight to individual CEs. This has significant implications for the interpretation of clinical trial data.

Indexed as

Patient PreferenceTreatment OutcomeAgedClinical Trials as TopicCoronary Artery BypassCoronary Artery DiseaseFemaleHumansMaleMyocardial InfarctionPercutaneous Coronary InterventionProspective StudiesRisk FactorsStrokebest-worst scalingcomposite endpointscoronary artery bypass graftingcoronary artery diseasepatient preferencespercutaneous coronary interventionrevascularizationweighting procedure

Identifiers

PMID30109764
PMCPMC6250862
OpenAlexW2886195982

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.